Promethazine

Promethazine

SCHEMBL2962420

CC(CN1c2ccccc2Sc2ccccc21)N(C)C.Cl.Cl

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

HRH1

The experimentally established mechanism targets of Promethazine. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HRH1 known ✓ P35367 3/20 0.97
LMNA P02545 4/20 1.00
MAPT P10636 3/20 1.00
SMN1; SMN2 Q16637 3/20 1.00
MAPK1 P28482 3/20 1.00
HIF1A Q16665 3/20 1.00
KMT2A Q03164 3/20 1.00
GFER P55789 3/20 1.00
PMP22 Q01453 2/20 1.00
GMNN O75496 1/20 1.00
BLM P54132 1/20 1.00
CYP2D6 P10635 7/20 0.97
CHRM2 P08172 6/20 0.97
HTR1A P08908 6/20 0.97
CHRM1 P11229 6/20 0.97
ADRA1A P35348 6/20 0.97
OPRM1 P35372 6/20 0.97
DRD3 P35462 6/20 0.97
KCNH2 Q12809 6/20 0.97
ADRA2A P08913 5/20 0.97

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Promethazine SCHEMBL5501515 1.00 LMNA (1.00) LMNAMAPTSMN1; SMN2MAPK1HIF1A
Promethazine SCHEMBL29390401 1.00 LMNA (1.00) LMNAMAPTSMN1; SMN2MAPK1HIF1A
Promethazine SCHEMBL5425141 1.00 LMNA (1.00) LMNAMAPTSMN1; SMN2MAPK1HIF1A
Promethazine SCHEMBL27559626 1.00 LMNA (1.00) LMNAMAPTSMN1; SMN2MAPK1HIF1A
Promethazine SCHEMBL41904 1.00 LMNA (1.00) LMNAMAPTSMN1; SMN2MAPK1HIF1A
Promethazine SCHEMBL3991025 0.98 LMNA (0.97) LMNAMAPTSMN1; SMN2MAPK1HIF1A
(S)-Promethazine SCHEMBL2900853 0.98 CYP2D6 (1.00) LMNAMAPTSMN1; SMN2MAPK1HIF1A
Promethazine SCHEMBL29372077 0.98 CYP2D6 (1.00) LMNAMAPTSMN1; SMN2MAPK1HIF1A
Promethazine SCHEMBL26777 0.98 CYP2D6 (1.00) LMNAMAPTSMN1; SMN2MAPK1HIF1A
Promethazine SCHEMBL4700 0.98 CYP2D6 (1.00) LMNAMAPTSMN1; SMN2MAPK1HIF1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 68 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2002256-B1 REFERENCE CONTROL COMPOSITION CONTAINING A NUCLEATED RED BLOOD CELL COMPONENT MADE OF NON-NUCLEATED BLOOD CELLS BECKMAN COULTER INC (US) 2017-10-18 EP disclosed
EP-2702414-B1 HEMATOLOGY CONTROL COMPOSITIONS WITH EXTENDED STABILITY BECKMAN COULTER INC (US) 2015-07-08 EP disclosed
EP-2082224-B1 HEMATOLOGY LINEARITY CONTROL COMPOSITION SYSTEM AND METHOD OF USE BECKMAN COULTER INC (US) 2015-05-13 EP disclosed
EP-1668353-B1 REFERENCE CONTROL FOR OPTICAL MEASUREMENT OF NUCLEATED RED BLOOD CELLS OF A BLOOD SAMPLE BECKMAN COULTER INC (US) 2015-03-18 EP disclosed
US-20140051063-A1 HEMATOLOGY CONTROL COMPOSITIONS WITH EXTENDED STABILITY BECKMAN COULTER, INC. (US) 2014-02-20 US disclosed
CN-101535804-B Hematology linearity control compositions, systems, and methods of use BECKMAN COULTER INC 2013-04-24 CN disclosed
EP-1766045-B1 HEMATOLOGY REFERENCE CONTROL CONTAINING AN IMMATURE GRANULOCYTE COMPONENT BECKMAN COULTER INC (US) 2010-12-01 EP disclosed
US-7754487-B2 Hematology linearity control composition, system and method of use BECKMAN COULTER, INC. (US) 2010-07-13 US disclosed
EP-2082224-A2 HEMATOLOGY LINEARITY CONTROL COMPOSITION SYSTEM AND METHOD OF USE Beckman Coulter, Inc. (US) 2009-07-29 EP disclosed
EP-1682865-A4 METHOD OF USING A REFERENCE CONTROL COMPOSITION FOR MEASUREMENT OF NUCLEATED RED BLOOD CELLS BECKMAN COULTER INC (US) 2009-03-18 EP disclosed
US-5320964-A Hematology control composition including leukocyte analogs; and methods for their preparation and use COULTER CORPORATION (US) 1994-06-14 US disclosed
WO-1993017329-A1 SUSPENSION MEDIA FOR HEMATOLOGICAL COMPOSITION AND METHOD FOR ITS USE COULTER CORPORATION (US) 1993-09-02 WO disclosed
WO-1993017330-A1 HEMATOLOGY CONTROL COMPOSITION FOR LEUKOCYTE ANALOGS; AND METHODS FOR THEIR PREPARATION AND USE COULTER CORPORATION (US) 1993-09-02 WO disclosed
EP-0181393-B1 HEMATOLOGY CONTROL COMPOSITIONS FOR THREE POPULATIONS OF LEUKOCYTES, AND METHODS FOR THEIR PREPARATION AND USE IN WHOLE BLOOD CONTROL SYSTEMS COULTER CORPORATION (US) 1992-09-09 EP disclosed
EP-0181393-A4 HEMATOLOGY CONTROL COMPOSITIONS FOR THREE POPULATIONS OF LEUKOCYTES, AND METHODS FOR THEIR PREPARATION AND USE IN WHOLE BLOOD CONTROL SYSTEMS. COULTER ELECTRONICS (US) 1988-09-07 EP disclosed
US-4704364-A CALIBRATION COULTER ELECTRONICS, INC. (US) 1987-11-03 US disclosed
EP-0181393-A1 HEMATOLOGY CONTROL COMPOSITIONS FOR THREE POPULATIONS OF LEUKOCYTES, AND METHODS FOR THEIR PREPARATION AND USE IN WHOLE BLOOD CONTROL SYSTEMS. COULTER ELECTRONICS (US) 1986-05-21 EP disclosed
WO-1985005450-A1 HEMATOLOGY CONTROL COMPOSITIONS FOR THREE POPULATIONS OF LEUKOCYTES: AND METHODS FOR THEIR PREPARATION AND USE IN WHOLE BLOOD CONTROL SYSTEMS COULTER ELECTRONICS, INC. (US) 1985-12-05 WO disclosed
US-4358394-A FOR DEVICES USING ELECTRONIC MEANS FOR WHOLE BLOOD DETERMINATIONS COULTER ELECTRONICS, INC. (US) 1982-11-09 US disclosed
US-4299726-A Process for preparing whole blood reference controls having long term stability, preconditioning diluent and media therefor COULTER ELECTRONICS, INC. (US) 1981-11-10 US disclosed